NCT04331444 is a NA clinical trial of CGM in Type 2 Diabetes Treated With Insulin, sponsored by Steno Diabetes Center Copenhagen.

Who is sponsoring NCT04331444?

NCT04331444 is sponsored by Steno Diabetes Center Copenhagen.

What drugs are being tested in NCT04331444?

Interventions in NCT04331444: CGM, training course, Peer-support.

What condition does NCT04331444 study?

NCT04331444 studies Type 2 Diabetes Treated With Insulin.

Is NCT04331444 still recruiting?

NCT04331444 is currently completed. Last updated 12 October 2023.

Last reviewed 2023-10-12 · How we verify

NCT04331444

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Steno2tech - Continuous Glucose Monitoring and Type 2 Diabetes.

Completed NA Last updated 12 October 2023

What this trial tests

NA trial testing CGM in Type 2 Diabetes Treated With Insulin in 96 participants. Completed in 1 July 2023.

Timeline

1 August 2020

Primary endpoint
1 July 2023

1 July 2023

Quick facts

Lead sponsor	Steno Diabetes Center Copenhagen
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	96
Start date	1 August 2020
Primary completion	1 July 2023
Estimated completion	1 July 2023
Sites	1 location across Denmark

Drugs / interventions tested

CGM
training course
Peer-support

Conditions studied

Type 2 Diabetes Treated With Insulin — all drugs for Type 2 Diabetes Treated With Insulin →

Sponsor

Steno Diabetes Center Copenhagen — full company profile →

Who can join

18 and older, any sex, with Type 2 Diabetes Treated With Insulin. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overall objective of this research study is to examine the effectiveness of the use of CGM vs. SMBG in persons with insulin-treated type 2 diabetes on glycemic variables and patient reported outcomes on treatment satisfaction, health behavior and wellbeing. The independent effect of peer-support will also be studied.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

A combined diabetes and continuous glucose monitoring education program for adults with type 2 diabetes.
Lind N, Christensen MB, Nørgaard K. · · 2024 · cited 5× · PMID 39161626 · DOI 10.1016/j.pecinn.2024.100324
Real-time continuous glucose monitoring versus self-monitoring of blood glucose in adults with insulin-treated type 2 diabetes: a protocol for a randomised controlled single-centre trial.
Lind N, Lindqvist Hansen D, Sætre Rasmussen S, Nørgaard K. · · 2021 · cited 4× · PMID 33452188 · DOI 10.1136/bmjopen-2020-040648
Silence, Awkwardness and Discomfort: Understanding How Health Interventions Fail-An Ethnographic Study of a Peer Support Intervention for People With Type 2 Diabetes in Denmark.
Anesen AA, Cleal B, Gammeltoft TM. · · 2025 · cited 1× · PMID 41014211 · DOI 10.1111/1467-9566.70088

Verify or expand the search:

Other trials of CGM

Trials testing the same drug.

NCT07477249 — Continuous Glucose Monitoring (CGM) in Prediabetes With Community Based Recruitment · NA · recruiting
NCT06863337 — Glucose Pattern in Infertile Women Receiving Assisted Reproduction Using Continuous Glucose Monitoring · NA · recruiting
NCT06883812 — Continuous Glucose Monitoring in Prediabetes With Health Education Videos Among Community Health Workers · NA · completed
NCT06586632 — The Steno Free Trial: AID to Adults with New-onset of Type 1 Diabetes · NA · not yet recruiting
NCT06226948 — Using the Visualization for Lifestyle Change in Patients At Risk of Cardiovascular Diseases · NA · completed

Other recruiting trials for Type 2 Diabetes Treated With Insulin

Currently open trials in the same condition.

NCT07063420 — Patient Centered Multi-Agent Decision Support System (PCM-DSS) for Healthcare Providers · NA · recruiting
NCT05317585 — Continuous Glucose Monitor Use in Pregnancy · NA · recruiting
NCT06311019 — The Effects of CGM and Connected Pen in T2DM Treated With Multiple Daily Insulin Injections · NA · active not recruiting

Other Steno Diabetes Center Copenhagen trials

Trials by the same sponsor.

NCT07485075 — Digital Support for Reducing Salt Intake Among Patients With Diabetic Kidney Disease: Protocol for a Controlled Clinical · NA · recruiting
NCT07427251 — The Postprandial Hypo-Avoid Study · Phase 4 · not yet recruiting
NCT06954090 — Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Study · Phase 4 · enrolling by invitation
NCT06832059 — Precision Nutrition Versus Standard Dietary Care: Continuous Glucose Monitoring as a Tool for Guided Nutrition Care in T · NA · recruiting
NCT07377266 — The Impact of Changing to a New Child- and Family-centered Outpatient Diabetes Clinic Focusing on Early Involvement of t · NA · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04331444 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Steno Diabetes Center Copenhagen
Last refreshed: 12 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04331444.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing